Physician profile
Samir Patel
NPI 1831604719
$3,311.48
in general payments reported to CMS, 2019-2025
16 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what 99% of Legal Medicine providers received nationally (typical 2025 total: $22.07).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,140 · 2022: $682 · 2023: $245 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,023 · Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,022.51 |
| Food and Beverage | $467.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,194.72 | 2025 | Spravato |
| Avanir Pharmaceuticals, INC. | $650.41 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $375.97 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $279.85 | 2022 | |
| Eisai INC. | $205.68 | 2021-2022 | |
| Abbvie INC. | $130.77 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $89.71 | 2023 | Austedo |
| Alkermes, INC. | $75.58 | 2023 | Aristada, Lybalvi |
| Indivior INC. | $72.71 | 2022 | |
| Acadia Pharmaceuticals INC | $69.57 | 2022-2023 | Nuplazid |
| Vanda Pharmaceuticals INC. | $53.87 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.41 | 2025 | Trintellix |
| Idorsia Pharmaceuticals US INC | $24.96 | 2022 | |
| Lundbeck LLC | $21.24 | 2023 | Rexulti |
| Tris Pharma INC | $18.93 | 2025 | Onyda Xr |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $17.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.